PIPELINE

TRC102

INDICATION
Mesothelioma
PHASE 2
Lung, Solid Tumors
PHASE 1

DE-122

INDICATION
Wet AMDSanten1
PHASE 2

TRC253

INDICATION
ProstateJanssen2
PHASE 2

TJ4309

INDICATION
TumorsI-Mab Biopharma3
PRE-CLINICAL

Bispecific Antibodies

INDICATION
TumorsI-Mab Biopharma3
PRE-CLINICAL

TRC205

INDICATION
Fibrosis
PRE-CLINICAL


1 Partnered with Santen Pharmaceutical Co., Ltd.
2 Janssen Pharmaceuticals retains a buyback option
3 Strategic partnership with I-Mab Biopharma